16-Jul-2008 - DSM is introducing application-specific versions of its Preventase enzyme; meanwhile, Novozymes is launching Acrylaway in Australia and New Zealand after having received regulatory approval.
08-Jul-2008 - Giant German supplier BASF has increased the price of propionic acid for the second time since May as energy and raw materials costs continue to spiral.
27-Jun-2008 - The enzymes market is experiencing some increased popularity among manufacturers because of their desired functionality and ability to help save costs, says a new report.
24-Jun-2008 - Acrylaway, the acrylamide-reducing enzyme from Novozymes, has received approval in a slate of countries worldwide and is now being applied across broad range of bakery and snack products.
17-Jun-2008 - The acrylamide-reducing enzyme Preventase has been granted approval for use in Switzerland, marking a new step down the road towards industry-wide adoption for biscuits and other baked goods.
16-Jun-2008 - Denmark's Chr Hansen is set to launch a second-generation Fermentation Produced Chymosin (FPC) for the cheese market, promising cost-efficiency and better process control.
02-Jun-2008 - Efforts to reduce acrylamide remain a priority as the European Food Safety Authority (EFSA) concludes risk assessments regarding the carcinogen will stay the same.
22-May-2008 - Cognis has announced an increase in the price of natural source vitamin E in North America for the first time in more than six years as input costs spiral.
22-Apr-2008 - Germany-based Gene Bridges has licensed its Red/ET Recombineering technology to Novozymes for genetically engineering recombinant micro-organisms for use in industrial applications.
08-Apr-2008 - Puratos and Novozymes have teamed up to develop a bio-solution to help industrial cake manufacturers increase the softness and freshness of their products, the companies have announced.
02-Apr-2008 - Denmark's Novozymes has signed an exclusive worldwide licensing agreement with CSL Behring for albufuse, a proprietary albumin fusion technology that can extend the circulatory half-life of therapeutic proteins through genetic fusion to recombinant human albumin.
18-Mar-2008 - Rising wheat prices have led AB Enzymes to promote a new application for Veron HF, which it says can be used to replace gluten in bakery products.